Breaking News Instant updates and real-time market news.

CNCE

Concert Pharmaceuticals

$6.23

-3.64 (-36.88%)

06:47
09/30/19
09/30
06:47
09/30/19
06:47

Concert Pharmaceuticals price target lowered to $18 from $29 at Mizuho

Mizuho analyst Difei Yang lowered her price target for Concert Pharmaceuticals to $18 from $29 after the company's partner Avanir on Friday reported negative top-line results from the second Phase 3 study of AVP-786 for the treatment of moderate-to-severe Alzheimer's agitation. The analyst no longer takes into account the AVP-786 program into Concert's valuation. However, she continues to believe Concert's CTP-543 has the potential of being best in case for treating Alopecia Areata, and she notes the company has about $6 per share in cash. Yang reiterates a Buy rating on Concert Pharmaceuticals.

  • 02

    Oct

  • 02

    Oct

CNCE Concert Pharmaceuticals
$6.23

-3.64 (-36.88%)

06/24/19
06/24/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Splunk (SPLK) assumed with an Overweight at Piper Jaffray. 2. HMS Holdings (HMSY) initiated with a Sector Weight at KeyBanc. 3. Concert Pharmaceuticals (CNCE) initiated with a Buy at SunTrust. 4. Armstrong World (AWI) resumed with a Buy at Deutsche Bank. 5. Rockwell Medical (RMTI) initiated with an Overweight at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/04/19
MZHO
09/04/19
NO CHANGE
Target $29
MZHO
Buy
Concert Pharmaceuticals price target raised to $29 from $23 at Mizuho
Mizuho analyst Difei Yang raised her price target for Concert Pharmaceuticals to $29 from $23 saying the company reported "strong" data from the ongoing Phase 2 clinical trial of CTP-543 for the treatment of alopecia areata. The analyst increased her probability of success for CTP-543 from 35% to 60% and reiterates a Buy rating on Concert shares. The analyst continues to see value in the stock, believing limited credit is currently assigned by the market for the company's clinical programs and management's ability to execute.
09/27/19
STFL
09/27/19
DOWNGRADE
STFL
Hold
Concert Pharmaceuticals downgraded to Hold from Buy at Stifel
09/27/19
STFL
09/27/19
DOWNGRADE
Target $8
STFL
Hold
Stifel downgrades Concert Pharmaceuticals after partner's Alzheimer trial fails
Stifel analyst Adam Walsh downgraded Concert Pharmaceuticals to Hold from Buy and cut his price target on the stock to $8 from $18 after partner Avanir reported that AVP-786's Phase 3 trial in Alzheimer's agitation failed. Avanir's press release on the news "disclosed little beyond the top-line failure," but with AVP-786 missed on both the primary and key secondary endpoints so Walsh said the "drug is now a show-me story at best." He has completely removed AVP-786 milestones and royalties from his estimates and thinks shares should be valued based solely on pipeline products CTP-543 and CTP-692, Walsh stated.

TODAY'S FREE FLY STORIES

ATLKY

Atlas Copco

$0.00

(0.00%)

05:18
11/15/19
11/15
05:18
11/15/19
05:18
Downgrade
Atlas Copco rating change  »

Atlas Copco downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SALRF

Salmar

$0.00

(0.00%)

05:16
11/15/19
11/15
05:16
11/15/19
05:16
Upgrade
Salmar rating change  »

Salmar upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$26.68

-1.42 (-5.05%)

05:14
11/15/19
11/15
05:14
11/15/19
05:14
Downgrade
CenterPoint Energy rating change  »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$0.00

(0.00%)

05:13
11/15/19
11/15
05:13
11/15/19
05:13
Downgrade
Daimler AG rating change  »

Daimler AG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWAV

ShockWave Medical

$36.47

1.38 (3.93%)

05:11
11/15/19
11/15
05:11
11/15/19
05:11
Syndicate
ShockWave Medical 2.482M share Secondary priced at $36.25 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

05:10
11/15/19
11/15
05:10
11/15/19
05:10
General news
FX Action: The yen is trading softer »

FX Action: The yen is…

BGNE

BeiGene

$195.90

-1.25 (-0.63%)

05:09
11/15/19
11/15
05:09
11/15/19
05:09
Recommendations
BeiGene analyst commentary  »

BeiGene price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 27

    Feb

NXTC

NextCure

$38.60

0.85 (2.25%)

05:09
11/15/19
11/15
05:09
11/15/19
05:09
Syndicate
NextCure 4.08M share Secondary priced at $36.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AAPL

Apple

$262.66

-1.86 (-0.70%)

05:05
11/15/19
11/15
05:05
11/15/19
05:05
Recommendations
Apple price target raised to $290 from $270 at Piper Jaffray »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$90.48

0.03 (0.03%)

, AAPL

Apple

$262.66

-1.86 (-0.70%)

04:59
11/15/19
11/15
04:59
11/15/19
04:59
Upgrade
Qualcomm upgraded to Buy from Neutral at Mizuho »

Mizuho analyst Vijay…

QCOM

Qualcomm

$90.48

0.03 (0.03%)

AAPL

Apple

$262.66

-1.86 (-0.70%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NUE

Nucor

$54.49

-0.2 (-0.37%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Nucor management to meet with KeyBanc »

Management participates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

INS

Intelligent Systems

$42.26

-0.34 (-0.80%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Intelligent Systems management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EXPI

eXp World Holdings

$9.97

-0.08 (-0.80%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
eXp World Holdings management to meet with DA Davidson »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

GSHD

Goosehead Insurance

$44.75

0.02 (0.04%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Goosehead Insurance management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 03

    Dec

04:55
11/15/19
11/15
04:55
11/15/19
04:55
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

October Industrial…

04:55
11/15/19
11/15
04:55
11/15/19
04:55
General news
Business Inventories to be reported at 10:00 »

September Business…

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
CLSA to hold a forum »

22nd CLSA India Forum…

04:55
11/15/19
11/15
04:55
11/15/19
04:55
General news
Breaking General news story  »

Week of 11/15…

TRGP

Targa Resources

$38.03

-0.28 (-0.73%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Targa Resources management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

UBX

Unity Biotechnology

$6.30

-0.26 (-3.96%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Unity Biotechnology management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 13

    Dec

CTSO

CytoSorbents

$4.24

-0.2 (-4.50%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
CytoSorbents management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

FTNT

Fortinet

$100.07

0.38 (0.38%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Fortinet management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 18

    Nov

  • 19

    Nov

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

LNDC

Landec

$11.05

0.195 (1.80%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Landec management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

SPR

Spirit AeroSystems

$89.60

0.31 (0.35%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Spirit AeroSystems management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.